LIPIODOL Drug Patent Profile
✉ Email this page to a colleague
When do Lipiodol patents expire, and what generic alternatives are available?
Lipiodol is a drug marketed by Guerbet and is included in one NDA.
The generic ingredient in LIPIODOL is ethiodized oil. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the ethiodized oil profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LIPIODOL?
- What are the global sales for LIPIODOL?
- What is Average Wholesale Price for LIPIODOL?
Summary for LIPIODOL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Clinical Trials: | 54 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for LIPIODOL |
What excipients (inactive ingredients) are in LIPIODOL? | LIPIODOL excipients list |
DailyMed Link: | LIPIODOL at DailyMed |
![LIPIODOL drug patent expirations Drug patent expirations by year for LIPIODOL](/p/graph/s/t/LIPIODOL-patent-expirations.png)
![Drug Prices for LIPIODOL](/p/graph/drug-price/LIPIODOL.png)
Recent Clinical Trials for LIPIODOL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
VA Office of Research and Development | Phase 1/Phase 2 |
National Cancer Institute (NCI) | Phase 2 |
City of Hope Medical Center | Phase 2 |
US Patents and Regulatory Information for LIPIODOL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Guerbet | LIPIODOL | ethiodized oil | OIL;INTRALYMPHATIC, INTRAUTERINE | 009190-001 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |